Kampala, Uganda
The National Institutes of Health admitted this week that it withheld potentially damaging results of research into an AIDS drug that the U.S. donated to Africa. In 2002, President Bush announced a $500 million program to provide African countries with stocks of nevirapine, a drug that helps prevent the transmission of HIV from mothers to babies during birth. Since then, thousands of African women have received the drug. But the NIH did not tell the White House that some of its research, particularly a study in Uganda, suggested a high level of adverse, even lethal, reactions to the drug. African doctors shrugged off the news, saying the drug had already saved thousands of lives. “What you may call a serious side effect in the U.S. is not a serious side effect in Kampala,” said Francis Mmiro, a lead doctor in the Uganda study.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
5 exclusive cartoons about Trump and Putin negotiating peaceCartoons Artists take on alternative timelines, missing participants, and more
-
The AI arms raceTalking Point The fixation on AI-powered economic growth risks drowning out concerns around the technology which have yet to be resolved
-
Why Jannik Sinner's ban has divided the tennis worldIn the Spotlight The timing of the suspension handed down to the world's best male tennis player has been met with scepticism
